3D Global Biotech Inc. (6808.TWO)
TWD 49.15
(-19.82%)
TWD 49.15
(-19.82%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -35.84 Million TWD | 37.13% |
| 2022 | -57.01 Million TWD | -59.18% |
| 2021 | -35.81 Million TWD | -49.03% |
| 2020 | -24.03 Million TWD | 3.94% |
| 2019 | -18.15 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 3.56 Million TWD | 131.18% |
| 2024 Q2 | 3.56 Million TWD | 0.0% |
| 2023 Q4 | -11.42 Million TWD | 0.0% |
| 2023 Q3 | -11.42 Million TWD | 3.41% |
| 2023 FY | - TWD | 37.13% |
| 2023 Q1 | -11.82 Million TWD | -3.58% |
| 2023 Q2 | -11.82 Million TWD | 0.0% |
| 2022 FY | - TWD | -59.18% |
| 2022 Q3 | -11.41 Million TWD | 0.0% |
| 2022 Q4 | -11.41 Million TWD | 0.0% |
| 2021 FY | - TWD | -49.03% |
| 2020 FY | - TWD | 3.94% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 22.485% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 109.107% |
| Level Biotechnology Inc. | 98.7 Million TWD | 136.317% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 19.878% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 50.293% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -42.06% |
| GlycoNex Incorporation | -126.82 Million TWD | 71.736% |
| VBI | -6.97 Million TWD | -414.142% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 75.054% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 264.356% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -102.223% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 65.405% |
| Visgeneer Inc. | 973 Thousand TWD | 3784.07% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 89.441% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 103.828% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 135.905% |
| Neith Corporation | -33.61 Million TWD | -6.653% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 96.383% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -1963.673% |
| Enimmune corporation | -228.96 Million TWD | 84.344% |
| TaiRx, Inc. | -208.64 Million TWD | 82.82% |
| CHO Pharma, Inc. | -277.73 Million TWD | 87.093% |
| EirGenix Inc. | -664.4 Million TWD | 94.605% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 148.503% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 151.843% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 96.654% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 68.308% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 202.893% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 42.5% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -36.297% |
| RBC Bioscience Corporation | 36.54 Million TWD | 198.082% |
| BiOptic Inc. | 65.03 Million TWD | 155.115% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 94.748% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -8.604% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 34.725% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 108.268% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 55.233% |
| NaviFUS Corp. | -55.79 Million TWD | 35.754% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -115.966% |
| Sinew Pharma Inc. | -163.63 Million TWD | 78.093% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 41.714% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 118.631% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 84.186% |
| AP Biosciences Inc | -325.51 Million TWD | 88.988% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 96.569% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 223.055% |
| Intech Biopharm Corporation | -219.58 Million TWD | 83.676% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 94.683% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 20.255% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 77.716% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 105.468% |
| TCI GENE Inc. | 25.98 Million TWD | 237.97% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 67.601% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 87.369% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 75.443% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 358.816% |
| PharmaEngine, Inc. | 347.3 Million TWD | 110.321% |
| Savior Lifetec Corporation | 219.6 Million TWD | 116.323% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 120.813% |
| OBI Pharma, Inc. | -855.08 Million TWD | 95.808% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 61.274% |
| Acepodia, Inc. | -764.51 Million TWD | 95.311% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 92.209% |